Alphabet Inc.
Source: SEC Form 13F · as of Mar 2026Alphabet Inc. holds 11 biotech & pharma companies tracked by BioSniper, totaling $426.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$426.9M
| Company | Shares | Value |
|---|---|---|
| RVMDREVOLUTION MEDICINES, INC. | 3,292,525 | $320.2M |
| MAZEMaze Therapeutics, Inc. | 1,388,583 | $41.4M |
| RLAYRelay Therapeutics, Inc. | 1,564,173 | $15.6M |
| GLUEMonte Rosa Therapeutics, Inc. | 684,275 | $11.3M |
| VERAVera Therapeutics, Inc. | 241,264 | $9.7M |
| SANASana Biotechnology, Inc. | 2,812,500 | $8.1M |
| BEAMBeam Therapeutics Inc. | 321,604 | $7.7M |
| LYELLyell Immunopharma, Inc. | 293,256 | $5.9M |
| OSCROscar Health Inc. | 481,988 | $5.5M |
| AUTLAutolus Therapeutics plc | 698,262 | $964K |
| TNYATenaya Therapeutics, Inc. | 915,705 | $632K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.